| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.52 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |